A recent study, published in Cell, suggests a systemically given small molecule could revive neural circuits in mice with spinal cord injury, restoring their ability to walk. The research, which was carried out at Boston Children’s Hospital (MA, USA), could complement regenerative therapies, aiding those with paralysis caused by spinal cord injury.
You may also be interested in...
Cell therapy weekly: ISCT warns against unproven T-cell cryopreservation attempts
Cell therapy weekly: Is stem cell transplant survival associated with procedure performance number?